FDA Adverse Event Injury Summary report: N

CERENE CRYOTHERAPY DEVICE

MDR report key: 23888879 · Received December 24, 2025

Report

Report Number
3012018285-2025-00011
Event Type
Injury
Date Received
December 24, 2025
Date of Event
November 25, 2025
Report Date
December 19, 2025
Manufacturer
CHANNEL MEDSYSTEMS, INC.
Product Code
MNB
PMA / PMN Number
P180032
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NC, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

INVESTIGATION OF THE DEVICE OR DEVICE HISTORY RECORDS WAS NOT POSSIBLE, AS AN UNKNOWN LOT NUMBER WAS REPORTED AND THE DEVICE WAS DISCARDED. THE LOT NUMBER WAS UNABLE TO BE ISOLATED AS THERE WERE MULTIPLE LOT NUMBERS SOLD TO THIS PHYSICIAN. VASOVAGAL RESPONSE IS COMMON DURING INTRAUTERINE PROCEDURES DUE TO CERVICAL/UTERINE STIMULATION TRIGGERING THE VAGUS NERVE AND LEADING TO PRESYNCOPE OR SYNCOPE. FOUR EPISODES OF PRESYNCOPE WERE REPORTED IN THE CLARITY PIVOTAL STUDY FOR THE CERENE CRYOTHERAPY DEVICE AND ARE REPORTED IN THE INSTRUCTIONS FOR USE.

Description of Event or Problem · 0

PRIOR TO TREATMENT WITH THE CERENE CRYOTHERAPY DEVICE, THE PATIENT RECEIVED A PARACERVICAL BLOCK AND TORADOL. DURING THE PROCEDURE, SHE WAS ADMINISTERED NITROUS OXIDE AND OXYGEN (PRONOX). THE PATIENT APPEARED TO BE TOLERATING THE PROCEDURE WELL WHEN, ABOUT 20 SECONDS BEFORE THE END OF TREATMENT, THE PATIENT BECAME UNRESPONSIVE TO THE NURSE. THE DEVICE WAS PLACED INTO VENTING MODE AND REMOVED FROM THE PATIENT. THE STAFF SUSPECTED A VASOVAGAL REACTION AND MOVED THE PATIENT TO THE FLOOR. THE PATIENT THEN BECAME RESPONSIVE AND HER VITALS RETURNED TO NORMAL WHEN TAKEN BY PARAMEDICS. THE PATIENT WAS TRANSFERRED TO THE HOSPITAL AS A PRECAUTION. IN FOLLOW-UP CONVERSATIONS WITH THE OFFICE ADMINISTRATOR TWO WEEKS LATER, IT WAS NOTED THAT THE PATIENT IS DOING WELL AND IS CURRENTLY ON VACATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2058083 CERENE CRYOTHERAPY DEVICE ENDOMETRIAL ABLATION DEVICE MNB CHANNEL MEDSYSTEMS, INC. FGS-7000

Patients

Seq Age Sex Outcome Treatment
1 NA Female Hospitalization NITROUS OXIDE/OXYGEN (PRONOX).| PARACERVICAL BLOCK.| TORADOL.